Medusa Mining unveils results of Bananghilig gold deposit study

Medusa Mining's shares surged Tuesday after the company reported an encouraging first pass scoping study on its Bananghilig gold deposit in the Philippines.

Medusa Mining's shares surged Tuesday after the company reported an encouraging first pass scoping study on its Bananghilig gold deposit in the Philippines.

The study indicated capital expenditure of $220m and mill operating expenses of $12 per tonne.

Cash costs were pegged at $565 per ounce with mining operating expenses of $15.50 per tonne, a strip ratio of 5:1 and indicative diluted head grade of 1.3 grams per tonne (g/t).

A mill with a capacity of 5.0m tonnes per annum is expected to produce 200,000 annualised ounces.

The Bananghilig deposit currently comprises an indicated resource of 11.9m tonnes at 1.59 g/t gold for 0.61m ounces and an inferred resource of 9.0m tonnes at 1.62 g/t gold for 0.47m ounces using a cut-off of 0.8 g/t gold.

Fourteen additional infill drill holes are nearing completion which will be incorporated into the data base and used to estimate a revised resource and the initial reserve which will be published in September.

It will form part of a feasibility study undertaken by external consultants.

"We are very pleased with the progress of the Bananghilig Project and the positive outcome of the scoping study, such that work has already commenced on additional studies to progress the feasibility study," said Managing Director Peter Hepburn-Brown.

"We are optimistic that the feasibility study will enhance the project economics which we are aiming to complete in the September quarter. We are also very optimistic, especially based on the sterilisation drilling results announced last week, that there is a real opportunity to extend the mine life significantly."

RD

Recommended

Imperial Brands has an 8.3% yield – but what’s the catch?
Share tips

Imperial Brands has an 8.3% yield – but what’s the catch?

Tobacco company Imperial Brands boasts an impressive dividend yield, and the shares look cheap. But investors should beware, says Rupert Hargreaves. H…
20 May 2022
Investing in drugmakers: uncommon profits from curing rare diseases
Share tips

Investing in drugmakers: uncommon profits from curing rare diseases

Treatments for medical conditions with only a small number of sufferers can still be very attractive for pharmaceutical companies and investors becaus…
20 May 2022
Share tips of the week – 20 May
Share tips

Share tips of the week – 20 May

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
20 May 2022
Delivering profits: should you buy Royal Mail shares?
Share tips

Delivering profits: should you buy Royal Mail shares?

The volume of parcels delivered by Royal Mail soared during the pandemic, and so did its profits. But it has been coming under pressure lately. So, as…
19 May 2022

Most Popular

The ten highest dividend yields in the FTSE 100
Income investing

The ten highest dividend yields in the FTSE 100

Rupert Hargreaves looks at the FTSE 100’s top yielding stocks for income investors to consider.
18 May 2022
Aviva: a share for income investors to tuck away
Share tips

Aviva: a share for income investors to tuck away

Insurance giant Aviva is one of the highest yielding stocks in the FTSE 100 – and it’s cheap, too, making it a tempting target for income investors. R…
18 May 2022
Despite the crypto crash, bitcoin still has a bright future
Bitcoin & crypto

Despite the crypto crash, bitcoin still has a bright future

Cryptocurrencies have crashed hard, with bitcoin down by more than 50% from its peak. But, says Dominic Frisby, bitcoin still has a future – it is the…
19 May 2022